Xyosted Injection
Product Images NDC 54436-275

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Xyosted (NDC 54436-275). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Antares Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100 mg/0.5 mL Carton (Carton100)

Packaging label for XYOSTED testosterone enanthate injection, USP 100 mg/0.5 mL, a subcutaneous single-dose autoinjector. The label includes usage instructions, storage conditions, warnings, manufacturer information (Antares Pharma, Inc.), and packaging contents. The label also displays the NDC code 54436-200-04 and highlights that the product is Rx only.*

FDA Label Image

50 mg/0.5 mL Carton (Carton50)

Box packaging label for XYOSTED testosterone enanthate injection, USP, 50 mg/0.5 mL strength. It is intended for subcutaneous injection using a single-dose autoinjector, marked Rx only. The label includes dosage instructions, storage information, and contains 4 autoinjectors with prefilled 0.5 mL syringes. Labeler is Antares Pharma, Inc.*

FDA Label Image

75 mg/0.5 mL Carton (Carton75)

XYOSTED injection, USP 75 mg/0.5 mL (testosterone enanthate) subcutaneous injection in single-dose autoinjector. The label shows usage instructions, caution against reuse, and federal law warnings. Contains 4 autoinjectors with 0.5 mL prefilled syringes. Manufactured by Antares Pharma, Inc. This is prescription drug packaging with dosage strength and storage guidance.*

FDA Label Image

100 mg/0.5 mL Autoinjector (Device100)

Label for XYOSTED injection, USP containing testosterone enanthate at 100 mg/0.5 mL for subcutaneous injection. The label indicates single-dose use with instructions to inject into the abdomen and hold for 10 seconds. Manufactured by Antares Pharma, Inc. The label includes storage instructions and a warning not to use if the seal is broken.*

FDA Label Image

50 mg/0.5 mL Autoinjector (Device50)

XYOSTED 50 mg/0.5 mL injection label for testosterone enanthate subcutaneous use. This is a single-dose autoinjector with instructions emphasizing injection only into the abdomen and to hold for 10 seconds. The label includes storage instructions, usage warnings, NDC 54436-250-02, and is manufactured by Antares Pharma, Inc.*

FDA Label Image

75 mg/0.5 mL Autoinjector (Device75)

XYOSTED testosterone enanthate injection label for 75 mg/0.5 mL subcutaneous use. The label includes dosage form, instructions for injection into the abdomen, dosage frequency guidance, storage instructions, and a warning not to use if the seal is broken. It also shows the labeler as Antares Pharma, Inc., and displays the NDC number 54436-275-02.*

FDA Label Image

Figure 1 (Figure1)

A line graph depicting the mean testosterone (TT) concentration in ng/dL with standard deviation over scheduled time in hours. The graph shows TT concentration rising sharply within the first 12 hours, peaking around 600-700 ng/dL, and gradually declining through 168 hours.*

FDA Label Image

Ifu Figure 1 (Ifu1)

Instructional diagram showing labeled parts of a XYOSTED (testosterone enanthate) subcutaneous injection auto-injector. It identifies the dosage strength label, viewing window to check medication, needle end covered by a safety seal cap, expiration date, and warnings not to remove the cap until ready to inject. The diagram includes an example strength of 75 mg/0.5 mL and illustrates the device from multiple angles for clarity.*

FDA Label Image

Ifu Disposal After Injection (Ifu10)

An instructional illustration showing the proper disposal of a syringe and needle into a bright orange sharps container labeled 'SHARPS'. It visually emphasizes safe handling and disposal of injection equipment to prevent injury and contamination.*

FDA Label Image

Ifu Record The Abdomen Injection Site (Ifu11)

An injection site record chart for XYOSTED testosterone enanthate subcutaneous injection. The chart includes columns for Date and Abdomen Site Used, with checkboxes under LEFT and RIGHT abdomen sites to help the user record injection locations for site rotation.*

FDA Label Image

Ifu Figure 2 (Ifu2)

Figure 2 is an illustration showing a portion of a device, likely related to subcutaneous injection administration. It depicts a close-up side view emphasizing a component with a needle or injector tip, a colored section, and a numbered label for reference.*

FDA Label Image

Ifu Figure 3 (Ifu3)

An instructional illustration showing the injection site for XYOSTED testosterone enanthate subcutaneous injection. The diagram highlights the left or right side of the abdomen as the recommended injection area, specifying to inject in the abdomen only.*

FDA Label Image

Ifu Figure 4 (Ifu4)

An instructional illustration showing two hands performing a twisting action. One hand holds a small cap or cover, and the other holds a pen-like injection device. The image guides users to twist the cap off the device before use, with a large arrow and the word 'TWIST' emphasizing the action.*

FDA Label Image

Ifu Figure 5 (Ifu5)

An instructional illustration showing hand placement to squeeze and hold the site for subcutaneous injection, depicting fingers pinching the skin on the abdomen over a pants waistband. The text 'SQUEEZE and HOLD SITE' is included to highlight the injection technique step.*

FDA Label Image

Ifu Figure 6 (Ifu6)

An instructional illustration showing how to administer XYOSTED testosterone enanthate subcutaneous injection. It depicts a hand holding a syringe perpendicular (90 degrees) to the skin area on the abdomen, indicating the angle for injection.*

FDA Label Image

Ifu Figure 7 (Ifu7)

Instructional illustration showing proper subcutaneous injection technique for XYOSTED injection. The image depicts a hand holding the injector device, pressing and holding it against the abdomen with an arrow indicating the direction to push for activating the injection.*

FDA Label Image

Ifu Figure 8 (Ifu8)

An instructional illustration showing a person holding an injection device against the abdomen subcutaneously. A clock icon indicates to hold the device in place for 10 seconds after injection. This image demonstrates the correct injection technique timing for XYOSTED testosterone enanthate subcutaneous injection.*

FDA Label Image

Ifu Figure 9 (Ifu9)

An instructional illustration showing a visual comparison labeled 'BEFORE Injection' and 'AFTER Injection.' The 'BEFORE Injection' side shows a container with a pale yellow liquid, while the 'AFTER Injection' side shows the same container filled with a red liquid, indicating a change due to the injection process.*

FDA Label Image

Testosterone Enanthate Structure (Structure)

Chemical structure of testosterone enanthate, showing the steroid nucleus with attached enanthate ester side chain.*

FDA Label Image

Warning Symbol (Warning)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.